Paper28056550
Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.
Murad HA and 5 others. Exp Biol Med (Maywood), 2017. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. Papers, record 28056550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28056550
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminopyridines | Major topic |
| Anti-Asthmatic Agents | Major topic |
| Asthma | Major topic |
| Benzamides | Major topic |
| Fluticasone | Major topic |
| Formoterol Fumarate | Major topic |
| Administration, Inhalation | |
| Animals | |
| Bronchoalveolar Lavage Fluid | |
| Cyclopropanes | |
| Disease Models, Animal | |
| Drug Therapy, Combination | |
| Female | |
| Immunoglobulin E | |
| Interleukin-4 | |
| Interleukin-5 | |
| Mice | |
| Mice, Inbred BALB C | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17452546 | Inverse associations of Helicobacter pylori with asthma and allergy. | Arch Intern Med | 2007 | https://conductscience.org/library/papers/17452546 | PubMed |
| 2 | 15994257 | Is the neutrophil the key effector cell in severe asthma? | Thorax | 2005 | https://conductscience.org/library/papers/15994257 | PubMed |
| 3 | 26064325 | FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26064325 | PubMed |
| 4 | 21335522 | Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints. | Am J Physiol Lung Cell Mol Physiol | 2011 | https://conductscience.org/library/papers/21335522 | PubMed |
| 5 | 25310957 | Influence of roflumilast on airway reactivity and apoptosis in ovalbumin-sensitized Guinea pigs. | Adv Exp Med Biol | 2015 | https://conductscience.org/library/papers/25310957 | PubMed |
| 6 | 16393727 | Roflumilast inhibition of pulmonary leukotriene production and bronchoconstriction in ovalbumin-sensitized and -challenged Guinea pigs. | J Asthma | 2005 | https://conductscience.org/library/papers/16393727 | PubMed |
| 7 | 24507418 | 2nd cross company respiratory symposium. | J Inflamm (Lond) | 2012 | https://conductscience.org/library/papers/24507418 | PubMed |
| 8 | 16126838 | Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/16126838 | PubMed |
| 9 | 18236728 | When should a methacholine challenge be ordered for a patient with suspected asthma? | Cleve Clin J Med | 2008 | https://conductscience.org/library/papers/18236728 | PubMed |
| 10 | 15860753 | Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. | Am J Respir Crit Care Med | 2005 | https://conductscience.org/library/papers/15860753 | PubMed |
| 11 | 11259554 | Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. | J Pharmacol Exp Ther | 2001 | https://conductscience.org/library/papers/11259554 | PubMed |
| 12 | 26296794 | Roflumilast for asthma: Efficacy findings in mechanism of action studies. | Pulm Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26296794 | PubMed |
| 13 | 9309991 | Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. | Am J Respir Crit Care Med | 1997 | https://conductscience.org/library/papers/9309991 | PubMed |
| 14 | 12944497 | In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12944497 | PubMed |
| 15 | 20381629 | The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. | Pulm Pharmacol Ther | 2010 | https://conductscience.org/library/papers/20381629 | PubMed |
| 16 | 14999617 | Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice. | J Infect Dis | 2004 | https://conductscience.org/library/papers/14999617 | PubMed |
| 17 | 24106801 | Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis. | Am J Respir Cell Mol Biol | 2014 | https://conductscience.org/library/papers/24106801 | PubMed |
| 18 | 26343938 | Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone? | J Allergy Clin Immunol | 2015 | https://conductscience.org/library/papers/26343938 | PubMed |
| 19 | 7512904 | Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. | Drugs | 1994 | https://conductscience.org/library/papers/7512904 | PubMed |
| 20 | 18307529 | Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. | Clin Exp Allergy | 2008 | https://conductscience.org/library/papers/18307529 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41711839 | Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41711839 | PubMed |
| 40534662 | Formoterol, the Most Effective Bronchodilator, Has No Anti-Inflammatory nor Metabolic Modulatory Effects in Severe Asthma Induced by Aspergillus fumigatus. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40534662 | PubMed |
| 38133375 | Impact of a Polymer-Based Nanoparticle with Formoterol Drug as Nanocarrier System In Vitro and in an Experimental Asthmatic Model. | Toxics | 2023 | https://conductscience.org/library/papers/38133375 | PubMed |
| 36865049 | Investigation of apoptotic and autophagic effects of chronic roflumilast use on testicular tissue in rats by immunohistochemical and immunofluorescence methods. | Iran J Basic Med Sci | 2023 | https://conductscience.org/library/papers/36865049 | PubMed |
| 35658632 | Isoorientin ameliorates OVA-induced asthma in a murine model of asthma. | Exp Biol Med (Maywood) | 2022 | https://conductscience.org/library/papers/35658632 | PubMed |
| 35239781 | Rectal roflumilast improves trinitrobenzenesulfonic acid-induced chronic colitis in rats. | Braz J Med Biol Res | 2022 | https://conductscience.org/library/papers/35239781 | PubMed |
| 34434103 | Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34434103 | PubMed |
| 33152094 | Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators. | Inflammopharmacology | 2021 | https://conductscience.org/library/papers/33152094 | PubMed |
| 31106094 | A Case of Persistent Asthma Resistant to Available Treatment Options: Management Dilemma. | Cureus | 2019 | https://conductscience.org/library/papers/31106094 | PubMed |
| 30122895 | Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/30122895 | PubMed |
| 29692733 | Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29692733 | PubMed |
| 28589151 | Advanced Role of Neutrophils in Common Respiratory Diseases. | J Immunol Res | 2017 | https://conductscience.org/library/papers/28589151 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28056550
GET https://conductscience.org/api/papers/v1/28056550/references?page=2